- Home
- LAB
as of 12-09-2025 4:00pm EST
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 449.9M | IPO Year: | 2011 |
| Target Price: | $1.35 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.34 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.92 - $2.25 | Next Earning Date: | 11-04-2025 |
| Revenue: | $169,737,000 | Revenue Growth: | 79.77% |
| Revenue Growth (this year): | -53.48% | Revenue Growth (next year): | -0.78% |
AI-Powered LAB Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Standard BioTools Inc. (LAB)
Director, 10% Owner
Avg Cost/Share
$1.45
Shares
150,000
Total Value
$217,020.00
Owned After
72,100,000
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.44
Shares
75,000
Total Value
$108,037.50
Owned After
72,100,000
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.42
Shares
125,000
Total Value
$177,512.50
Owned After
72,100,000
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.30
Shares
7,550,000
Total Value
$9,838,405.00
Owned After
72,100,000
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.43
Shares
150,000
Total Value
$214,875.00
Owned After
72,100,000
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.30
Shares
450,000
Total Value
$586,260.00
Owned After
72,100,000
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.28
Shares
350,000
Total Value
$448,910.00
Owned After
72,100,000
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.23
Shares
275,000
Total Value
$339,405.00
Owned After
72,100,000
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.22
Shares
225,000
Total Value
$275,580.00
Owned After
72,100,000
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$1.24
Shares
250,000
Total Value
$309,800.00
Owned After
72,100,000
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L.P. | LAB | Director, 10% Owner | Dec 4, 2025 | Buy | $1.45 | 150,000 | $217,020.00 | 72,100,000 | |
| Casdin Partners Master Fund, L.P. | LAB | Director, 10% Owner | Dec 3, 2025 | Buy | $1.44 | 75,000 | $108,037.50 | 72,100,000 | |
| Casdin Partners Master Fund, L.P. | LAB | Director, 10% Owner | Dec 2, 2025 | Buy | $1.42 | 125,000 | $177,512.50 | 72,100,000 | |
| Casdin Partners Master Fund, L.P. | LAB | Director, 10% Owner | Nov 25, 2025 | Buy | $1.30 | 7,550,000 | $9,838,405.00 | 72,100,000 | |
| Casdin Partners Master Fund, L.P. | LAB | Director, 10% Owner | Nov 24, 2025 | Buy | $1.43 | 150,000 | $214,875.00 | 72,100,000 | |
| Casdin Partners Master Fund, L.P. | LAB | Director, 10% Owner | Nov 20, 2025 | Buy | $1.30 | 450,000 | $586,260.00 | 72,100,000 | |
| Casdin Partners Master Fund, L.P. | LAB | Director, 10% Owner | Nov 19, 2025 | Buy | $1.28 | 350,000 | $448,910.00 | 72,100,000 | |
| Casdin Partners Master Fund, L.P. | LAB | Director, 10% Owner | Nov 18, 2025 | Buy | $1.23 | 275,000 | $339,405.00 | 72,100,000 | |
| Casdin Partners Master Fund, L.P. | LAB | Director, 10% Owner | Nov 17, 2025 | Buy | $1.22 | 225,000 | $275,580.00 | 72,100,000 | |
| Casdin Partners Master Fund, L.P. | LAB | Director, 10% Owner | Nov 14, 2025 | Buy | $1.24 | 250,000 | $309,800.00 | 72,100,000 |
Compare LAB vs Leading Stocks
See how LAB stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LAB Standard BioTools Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.